![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/28 | (2006.01) |
C07K 16/2818 | (2013.01) | ||
A61K 39/00 | (2006.01) | ||
A61K2039/545 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
C07K2317/24 | (2013.01) | ||
C07K2317/94 | (2013.01) | ||
C07K 16/2878 | (2013.01) | ||
A61K2039/53 | (2013.01) | ||
C07K2317/55 | (2013.01) | ||
C07K2317/74 | (2013.01) | ||
A61K 39/3955 | (2013.01) | ||
C07K2317/76 | (2013.01) | ||
C07K2317/33 | (2013.01) | ||
C07K2317/92 | (2013.01) | ||
A61K2039/505 | (2013.01) | ||
A61K2039/507 | (2013.01) | ||
A61P 1/02 | (2018.01) | ||
A61P 1/04 | (2018.01) | ||
A61P 1/16 | (2018.01) | ||
A61P 1/18 | (2018.01) | ||
A61P 11/00 | (2018.01) | ||
A61P 13/08 | (2018.01) | ||
A61P 13/10 | (2018.01) | ||
A61P 13/12 | (2018.01) | ||
A61P 15/00 | (2018.01) | ||
A61P 17/00 | (2018.01) | ||
A61P 19/00 | (2018.01) | ||
A61P 21/00 | (2018.01) | ||
A61P 25/00 | (2018.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 43/00 | (2018.01) | ||
A61P 5/00 | (2018.01) | ||
A61K 39/0011 | (2013.01) |
(11) | Number of the document | 3230319 |
(13) | Kind of document | T |
(96) | European patent application number | 15808464.0 |
Date of filing the European patent application | 2015-12-02 | |
(97) | Date of publication of the European application | 2017-10-18 |
(45) | Date of publication and mention of the grant of the patent | 2022-09-07 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2015/059268 |
Date | 2015-12-02 |
(87) | Number | WO 2016/092419 |
Date | 2016-06-16 |
(30) | Number | Date | Country code |
201462089658 P | 2014-12-09 | US | |
201562242750 P | 2015-10-16 | US | |
201562251973 P | 2015-11-06 | US |
(72) |
ABDICHE, Yasmina Noubia , US
CHO, Helen Kim , US
HO, Weihsien , US
JOOSS, Karin Ute , US
RAJPAL, Arvind , US
YOUSSEF, Sawsan , US
|
(73) |
Rinat Neuroscience Corp. ,
235 East 42nd Street, New York, NY 10017,
US
|
(54) | ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF |
ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF |